Biolog-id annonce le déploiement de sa solution chez We Are Blood, un important centre de transfusion sanguine desservant le centre du Texas (US)
October 06, 2022 00:01 ET
|
Biolog-id
ATLANTA, 06 oct. 2022 (GLOBE NEWSWIRE) -- Biolog-id a annoncé aujourd'hui qu'elle déploiera sa solution d'optimisation de la chaîne de valeur chez We Are Blood, un centre de transfusion sanguine à...
Biolog-id Announces Deployment of its Value-Chain-Optimization Solution at We Are Blood, a Major Blood Center Serving Central Texas
October 06, 2022 00:01 ET
|
Biolog-id
ATLANTA, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Biolog-id announced today that it will deploy its value-chain-optimization solution at We Are Blood, an Austin-based nonprofit blood center that serves...
La société Biolog-id lance un kit RFID Haute Densité (HD) innovant
October 04, 2022 00:01 ET
|
Biolog-id
Fort de l'expérience réussie acquise auprès de nos clients aux États-Unis et dans la région Asie-Pacifique, l'adoption du kit HD s'étend maintenant à plusieurs régions géographiques. ATLANTA, 04...
Biolog-id Launches an Innovative High-Density (HD) RFID Kit Targeting the High-Volume Needs of Blood Centers and Large Hospital Blood Banks
October 04, 2022 00:01 ET
|
Biolog-id
ATLANTA, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Biolog-id announced the launch of an innovative RFID kit designed specifically for organizations with high volumes of Red Blood Cells (RBC). Following...
Biolog-id completed phase one of deploying its value-chain optimization solution in a multi-state integrated delivery network in the southeast USA
September 30, 2022 10:00 ET
|
Biolog-id
ATLANTA, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Biolog-id has completed phase one of implementing its value-chain optimization solution in a large medical center and level II trauma center in North...
Biolog-id a achevé la première phase du déploiement de sa solution d'optimisation de la chaîne de valeur dans un groupement d'hôpitaux présents sur plusieurs états dans le sud-est des États-Unis
September 30, 2022 10:00 ET
|
Biolog-id
ATLANTA, 30 sept. 2022 (GLOBE NEWSWIRE) -- Biolog-id a terminé la première phase de la mise en œuvre de sa solution d'optimisation de la chaîne de valeur dans un établissement hospitalier majeur qui...
Biolog-id and Genesis Growth Tech Acquisition Corp. Announce Execution of Business Combination Agreement for Proposed Merger to Create Publicly Listed Digital Health Solutions Company Focused on Value Chain Optimization
September 08, 2022 01:00 ET
|
Biolog-id
BERNAY, France and NIDWALDEN, Switzerland, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Biolog-id, a digital health solution provider focusing on value-chain optimization, and Genesis Growth Tech Acquisition...
Biolog-id and Genesis Growth Tech Acquisition Corp. Announce Execution of Memorandum of Understanding for a Proposed Merger to Create Publicly Listed Digital Health Solutions Company Focused on Value Chain Optimization
August 23, 2022 08:00 ET
|
Biolog-id
BERNAY, France and NIDWALDEN, Switzerland , Aug. 23, 2022 (GLOBE NEWSWIRE) -- Biolog-id, a digital health solution provider focusing on value-chain optimization, and Genesis Growth Tech Acquisition...
L'expérience accumulée pendant 18 mois à l'Hôpital du District de Santarém au Portugal démontre l'impact significatif de la solution de Biolog-id
August 04, 2022 00:01 ET
|
Biolog-id
PARIS, 04 août 2022 (GLOBE NEWSWIRE) -- L'Hospital Distrital de Santarém (HDS) fait partie du Service National de Santé Portugais et dessert une population d'environ 200 000 personnes dans la...
Experience Accumulated Over 18 Months in Santarém District Hospital in Portugal Demonstrates Significant Impact of Biolog-id Solution
August 04, 2022 00:01 ET
|
Biolog-id
PARIS, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The Hospital Distrital de Santarém (HDS) is part of the Portuguese National Health Service, and servs a population of approximately 200,000 people in the...